tetano
Editor, Senior Moderator
Diagnostics (Basel)
. 2021 Dec 30;12(1):81.
doi: 10.3390/diagnostics12010081.
Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) in Various Respiratory Diseases: A Retrospective Analysis
Milena-Adina Man[SUP] 1 [/SUP], Lavinia Davidescu[SUP] 2 [/SUP], Nicoleta-Stefania Motoc[SUP] 1 [/SUP], Ruxandra-Mioara Rajnoveanu[SUP] 1 [/SUP], Cosmina-Ioana Bondor[SUP] 3 [/SUP], Carmen-Monica Pop[SUP] 1 [/SUP], Claudia Toma[SUP] 4 [/SUP]
Affiliations
Abstract
The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte (PLR) ratio are two extensively used inflammatory markers that have been proved very useful in evaluating inflammation in several diseases. The present article aimed to investigate if they have any value in distinguishing among various respiratory disorders. One hundred and forty-five patients with coronavirus disease 2019 (COVID-19), 219 patients with different chronic respiratory diseases (interstitial lung disease, obstructive sleep apnea(OSA)-chronic obstructive pulmonary disease (COPD) overlap syndrome, bronchiectasis) and 161 healthy individuals as a control group were included in the study. While neither NLR nor PLR had any power in differentiating between various diseases, PLR was found to be significant but poor as a diagnostic test when the control group was compared with the OSA-COPD group. NLR was found to be significant but poor as a diagnostic test when we compared the control group with all three groups (separately): the OSA-COPD group; interstitial lung disease group, and bronchiectasis group. NLR and PLR had poor power to discriminate between various respiratory diseases and cannot be used in making the differential diagnosis.
Keywords: inflammatory markers; neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte (PLR); respiratory diseases.
. 2021 Dec 30;12(1):81.
doi: 10.3390/diagnostics12010081.
Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) in Various Respiratory Diseases: A Retrospective Analysis
Milena-Adina Man[SUP] 1 [/SUP], Lavinia Davidescu[SUP] 2 [/SUP], Nicoleta-Stefania Motoc[SUP] 1 [/SUP], Ruxandra-Mioara Rajnoveanu[SUP] 1 [/SUP], Cosmina-Ioana Bondor[SUP] 3 [/SUP], Carmen-Monica Pop[SUP] 1 [/SUP], Claudia Toma[SUP] 4 [/SUP]
Affiliations
- PMID: 35054248
- DOI: 10.3390/diagnostics12010081
Abstract
The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte (PLR) ratio are two extensively used inflammatory markers that have been proved very useful in evaluating inflammation in several diseases. The present article aimed to investigate if they have any value in distinguishing among various respiratory disorders. One hundred and forty-five patients with coronavirus disease 2019 (COVID-19), 219 patients with different chronic respiratory diseases (interstitial lung disease, obstructive sleep apnea(OSA)-chronic obstructive pulmonary disease (COPD) overlap syndrome, bronchiectasis) and 161 healthy individuals as a control group were included in the study. While neither NLR nor PLR had any power in differentiating between various diseases, PLR was found to be significant but poor as a diagnostic test when the control group was compared with the OSA-COPD group. NLR was found to be significant but poor as a diagnostic test when we compared the control group with all three groups (separately): the OSA-COPD group; interstitial lung disease group, and bronchiectasis group. NLR and PLR had poor power to discriminate between various respiratory diseases and cannot be used in making the differential diagnosis.
Keywords: inflammatory markers; neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte (PLR); respiratory diseases.